OABI stock

  • OmniAb Jumps 13% on Eli Lilly Ion Channel Collaboration

    OmniAb Jumps 13% on Eli Lilly Ion Channel Collaboration

    OmniAb landed a partner with deep pockets on Monday. Acurx Pharmaceuticals landed something smaller but just as telling: a brand name regulators are willing to put on a drug label. Neither event is an approval. Both moved the stock like one. OmniAb Jumps 13% on Eli Lilly Collaboration Worth Up to $370 Million OmniAb (Nasdaq:…

    read more